Startseite>>Signaling Pathways>> Neuroscience>> nAChR>>Vecuronium Bromide

Vecuronium Bromide (Synonyms: NC 45)

Katalog-Nr.GC11210

Vecuronium (ORG NC 45) Bromid ist ein nicht-depolarisierender neuromuskulÄrer Blocker, der auch als nikotinerger Acetylcholinrezeptor (nAChR)-Hemmer und Muskelrelaxans wirkt und zur prÄoperativen AnÄsthesie eingesetzt werden kann.

Products are for research use only. Not for human use. We do not sell to patients.

Vecuronium Bromide Chemische Struktur

Cas No.: 50700-72-6

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
37,00 $
Auf Lager
25mg
35,00 $
Auf Lager
100mg
94,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Vecuronium bromide is a nondepolarizing neuromuscular blocking agent of intermediate duration.

References:
[1]. Meretoja, O.A., Vecuronium infusion requirements in pediatric patients during fentanyl-N2O-O2 anesthesia. Anesth Analg, 1989. 68(1): p. 20-4.
[2]. Agoston, S., et al., The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study. Br J Anaesth, 1980. 52 Suppl 1: p. 53S-59S.
[3]. Shingu, K., et al., [Neuromuscular blocking effects of Org 9426 (rocuronium bromide); a comparative study with vecuronium bromide in Japanese patients]. Masui, 2006. 55(9): p. 1140-8.

Bewertungen

Review for Vecuronium Bromide

Average Rating: 5 ★★★★★ (Based on Reviews and 31 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Vecuronium Bromide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.